Beatriz A. B. R. Passos, Matteo Battaglini, Gianni Ciofani
{"title":"纳米结构生物材料支持诱导多能干细胞分化的方法","authors":"Beatriz A. B. R. Passos, Matteo Battaglini, Gianni Ciofani","doi":"10.1002/anbr.202500072","DOIUrl":null,"url":null,"abstract":"<p>The possibility to control the proliferation of stem cells and guide their differentiation toward specific cellular lineages holds great promise as a potential therapeutic approach for regenerating and substituting damaged tissues, and in the treatment of several human diseases. In recent years, developing strategies for obtaining induced pluripotent stem cells (iPSCs) from adult tissues has been a groundbreaking scientific discovery; the rationale behind the exploitation of iPSCs in therapy consists in the isolation of adult cells, their reprogramming into iPSCs, and the subsequent differentiation into somatic cells. However, traditional differentiation procedures usually cannot finely tune and control the differentiation of iPSCs, leading to undesired cellular subpopulations and potentially adverse effects in the case of cellular grafting in adult tissues. In this context, nanostructured biomaterial-based approaches for the guided differentiation of iPSCs represent a promising tool for overcoming the limitations of traditional protocols. This review aims to provide the current state of the art concerning the exploitation of nanostructured biomaterials (scaffolds or nanocarriers) to control and tune the differentiation processes of iPSCs. With this work, it is hoped to provide new insights and perspectives into biomaterial designing and application strategies in the context of iPSC-based studies.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"5 10","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://advanced.onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202500072","citationCount":"0","resultStr":"{\"title\":\"Nanostructured Biomaterial-Based Approaches to Support Induced Pluripotent Stem Cell Differentiation\",\"authors\":\"Beatriz A. B. R. Passos, Matteo Battaglini, Gianni Ciofani\",\"doi\":\"10.1002/anbr.202500072\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The possibility to control the proliferation of stem cells and guide their differentiation toward specific cellular lineages holds great promise as a potential therapeutic approach for regenerating and substituting damaged tissues, and in the treatment of several human diseases. In recent years, developing strategies for obtaining induced pluripotent stem cells (iPSCs) from adult tissues has been a groundbreaking scientific discovery; the rationale behind the exploitation of iPSCs in therapy consists in the isolation of adult cells, their reprogramming into iPSCs, and the subsequent differentiation into somatic cells. However, traditional differentiation procedures usually cannot finely tune and control the differentiation of iPSCs, leading to undesired cellular subpopulations and potentially adverse effects in the case of cellular grafting in adult tissues. In this context, nanostructured biomaterial-based approaches for the guided differentiation of iPSCs represent a promising tool for overcoming the limitations of traditional protocols. This review aims to provide the current state of the art concerning the exploitation of nanostructured biomaterials (scaffolds or nanocarriers) to control and tune the differentiation processes of iPSCs. With this work, it is hoped to provide new insights and perspectives into biomaterial designing and application strategies in the context of iPSC-based studies.</p>\",\"PeriodicalId\":29975,\"journal\":{\"name\":\"Advanced Nanobiomed Research\",\"volume\":\"5 10\",\"pages\":\"\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-06-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://advanced.onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202500072\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced Nanobiomed Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://advanced.onlinelibrary.wiley.com/doi/10.1002/anbr.202500072\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://advanced.onlinelibrary.wiley.com/doi/10.1002/anbr.202500072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Nanostructured Biomaterial-Based Approaches to Support Induced Pluripotent Stem Cell Differentiation
The possibility to control the proliferation of stem cells and guide their differentiation toward specific cellular lineages holds great promise as a potential therapeutic approach for regenerating and substituting damaged tissues, and in the treatment of several human diseases. In recent years, developing strategies for obtaining induced pluripotent stem cells (iPSCs) from adult tissues has been a groundbreaking scientific discovery; the rationale behind the exploitation of iPSCs in therapy consists in the isolation of adult cells, their reprogramming into iPSCs, and the subsequent differentiation into somatic cells. However, traditional differentiation procedures usually cannot finely tune and control the differentiation of iPSCs, leading to undesired cellular subpopulations and potentially adverse effects in the case of cellular grafting in adult tissues. In this context, nanostructured biomaterial-based approaches for the guided differentiation of iPSCs represent a promising tool for overcoming the limitations of traditional protocols. This review aims to provide the current state of the art concerning the exploitation of nanostructured biomaterials (scaffolds or nanocarriers) to control and tune the differentiation processes of iPSCs. With this work, it is hoped to provide new insights and perspectives into biomaterial designing and application strategies in the context of iPSC-based studies.
期刊介绍:
Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science.
The scope of Advanced NanoBiomed Research will cover the following key subject areas:
▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging.
▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications.
▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture.
▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs.
▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization.
▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems.
with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.